Filter posts

Pharmaceuticals Play a Key Role in Value-Based Care

By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have …

2 FIELDS 1 GOAL: Protecting the Integrity of Science and Sport

In just over a week, the eyes of the world will fall on London as …

FDA Safety and Innovation Act: A Step Forward for Patients With Rare Diseases

By Peter L. Saltonstall, President and CEO, National Organization for Rare Disorders (NORD) The Food …

Vaccines Beyond 2012

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority …

The Cause Endures

By David Welch, M2 MultiMedia Communications In producing this short form mini-documentary, I learned that …

Analysis and Impact of PDUFA V

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug …

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the …

From Bench to Bedside in a Bioeconomy

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program …

Biotech Companies are Bringing Innovation to Global Health

By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures …

Take the PKD Foundation Challenge

By Jill Panetta, Chief Scientific Officer, PKD Foundation Polycystic Kidney Disease (PKD) Awareness Week has …